HUMA
Closed
Humacyte Inc
2.28
+0.19 (+9.09%)
Last Update: 01 Jul 2025 23:19:00
Yesterday: 2.09
Day's Range: 2.08 - 2.395
Send
sign up or login to leave a comment!
When Written:
3.02
Humacyte Inc is a biotechnology company that develops and manufactures bioengineered human tissues and organs for transplantation. The company was founded in 2004 and is headquartered in Durham, North Carolina.
Humacyte's technology involves growing human cells on a biodegradable scaffold to create tissues and organs that can be transplanted into patients without the risk of rejection. The company's lead product is a bioengineered blood vessel called Humacyl, which is being developed for use in patients with end-stage renal disease who require hemodialysis access.
Humacyte has received significant funding from venture capital firms and has partnerships with major pharmaceutical companies, including Roche and Pfizer. The company has also received grants from the U.S. Department of Defense and the National Institutes of Health to support its research and development efforts.
Humacyte has been recognized for its innovative technology and has received numerous awards, including being named a Technology Pioneer by the World Economic Forum and a Top Innovator by the Cleveland Clinic.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Humacyte's technology involves growing human cells on a biodegradable scaffold to create tissues and organs that can be transplanted into patients without the risk of rejection. The company's lead product is a bioengineered blood vessel called Humacyl, which is being developed for use in patients with end-stage renal disease who require hemodialysis access.
Humacyte has received significant funding from venture capital firms and has partnerships with major pharmaceutical companies, including Roche and Pfizer. The company has also received grants from the U.S. Department of Defense and the National Institutes of Health to support its research and development efforts.
Humacyte has been recognized for its innovative technology and has received numerous awards, including being named a Technology Pioneer by the World Economic Forum and a Top Innovator by the Cleveland Clinic.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!